Korean Journal of Radiology

  • 제14권6호
  • /
  • Pages.894-904
  • /
  • 2013
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic Acid

  • Lee, Kyung Hee (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) ;
  • Lee, Jeong Min (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) ;
  • Park, Ji Hoon (Division of Abdominal Imaging, Department of Radiology, Seoul National University Bundang Hospital) ;
  • Kim, Jung Hoon (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) ;
  • Park, Hee Sun (Department of Radiology, Konkuk University School of Medicine) ;
  • Yu, Mi Hye (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) ;
  • Yoon, Jeong-Hee (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) ;
  • Han, Joon Koo (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) ;
  • Choi, Byung Ihn (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine)
  • 투고 : 2013.02.14
  • 심사 : 2013.08.04
  • 발행 : 2013.11.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To compare the diagnostic performance of gadoxetic acid-enhanced magnetic resonance (MR) imaging with that of triple-phase multidetector-row computed tomography (MDCT) in the detection of liver metastasis. Materials and Methods: Our institutional review board approved this retrospective study and waived informed consent. The study population consisted of 51 patients with hepatic metastases and 62 patients with benign hepatic lesions, who underwent triple-phase MDCT and gadoxetic acid-enhanced MRI within one month. Two radiologists independently and randomly reviewed MDCT and MRI images regarding the presence and probability of liver metastasis. In order to determine additional value of hepatobiliary-phase (HBP), the dynamic-MRI set alone and combined dynamic-and-HBP set were evaluated, respectively. The standard of reference was a combination of pathology diagnosis and follow-up imaging. For each reader, diagnostic accuracy was compared using the jackknife alternative free-response receiver-operating-characteristic (JAFROC). Results: For both readers, average JAFROC figure-of-merit (FOM) was significantly higher on the MR image sets than on the MDCT images: average FOM was 0.582 on the MDCT, 0.788 on the dynamic-MRI set and 0.847 on the combined HBP set, respectively (p < 0.0001). The differences were more prominent for small (${\leq}$ 1 cm) lesions: average FOM values were 0.433 on MDCT, 0.711 on the dynamic-MRI set and 0.828 on the combined HBP set, respectively (p < 0.0001). Sensitivity increased significantly with the addition of HBP in gadoxetic acid-enhanced MR imaging (p < 0.0001). Conclusion: Gadoxetic acid-enhanced MRI shows a better performance than triple-phase MDCT for the detection of hepatic metastasis, especially for small (${\leq}$ 1 cm) lesions.

키워드

참고문헌

  1. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liverspecific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52 https://doi.org/10.2463/mrms.6.43
  2. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-337 https://doi.org/10.1148/radiology.197.2.7480672
  3. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000;174:691-698 https://doi.org/10.2214/ajr.174.3.1740691
  4. Clement O, Muhler A, Vexler VS, Kuwatsuru R, Berthezene Y, Rosenau W, et al. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors. J Magn Reson Imaging 1993;3:71-77 https://doi.org/10.1002/jmri.1880030113
  5. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial. J Comput Assist Tomogr 2006;30:345-354 https://doi.org/10.1097/00004728-200605000-00001
  6. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. Radiology 2005;234:468-478 https://doi.org/10.1148/radiol.2342040278
  7. Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67 https://doi.org/10.1148/radiology.200.1.8657946
  8. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011;34:326-335 https://doi.org/10.1002/jmri.22613
  9. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792 https://doi.org/10.1148/radiology.195.3.7754011
  10. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, et al. Phase II clinical evaluation of Gd-EOBDTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199:177-183 https://doi.org/10.1148/radiology.199.1.8633143
  11. Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009;192:1675-1681 https://doi.org/10.2214/AJR.08.1262
  12. Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging. Eur J Radiol 2010;73:131-136 https://doi.org/10.1016/j.ejrad.2008.09.027
  13. Lee MH, Kim SH, Kim H, Lee MW, Lee WJ. Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging. Korean J Radiol 2011;12:439-449 https://doi.org/10.3348/kjr.2011.12.4.439
  14. Park Y, Kim SH, Kim SH, Jeon YH, Lee J, Kim MJ, et al. Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience. Korean J Radiol 2010;11:433-440 https://doi.org/10.3348/kjr.2010.11.4.433
  15. Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006;6:33-42 https://doi.org/10.1102/1470-7330.2006.0007
  16. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010;45:133-141 https://doi.org/10.1097/RLI.0b013e3181caea5b
  17. Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol 2009;193:W490-W496 https://doi.org/10.2214/AJR.08.1732
  18. Lowenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 2011;21:832-840 https://doi.org/10.1007/s00330-010-1977-2
  19. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010;20:2690-2698 https://doi.org/10.1007/s00330-010-1842-3
  20. Motosugi U, Ichikawa T, Onohara K, Sou H, Sano K, Muhi A, et al. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Invest Radiol 2011;46:359-365 https://doi.org/10.1097/RLI.0b013e3182104b77
  21. Ahn SJ, Kim MJ, Hong HS, Kim KA, Song HT. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid. J Magn Reson Imaging 2011;34:310-317 https://doi.org/10.1002/jmri.22658
  22. Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009;19:342-357 https://doi.org/10.1007/s00330-008-1172-x
  23. Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003;181:809-817 https://doi.org/10.2214/ajr.181.3.1810809
  24. Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, et al. Dynamic MR imaging of liver metastases with Gd-EOBDTPA. Acta Radiol 2000;41:255-262 https://doi.org/10.1080/028418500127345208
  25. Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 2011;260:446-453 https://doi.org/10.1148/radiol.11103548
  26. Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, et al. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 2013;267:776-786 https://doi.org/10.1148/radiol.13120775
  27. Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, et al. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol 2010;45:96-103 https://doi.org/10.1097/RLI.0b013e3181c5faf7
  28. Chakraborty DP. Analysis of location specific observer performance data: validated extensions of the jackknife freeresponse (JAFROC) method. Acad Radiol 2006;13:1187-1193 https://doi.org/10.1016/j.acra.2006.06.016
  29. Chakraborty DP, Berbaum KS. Observer studies involving detection and localization: modeling, analysis, and validation. Med Phys 2004;31:2313-2330 https://doi.org/10.1118/1.1769352
  30. Vikgren J, Zachrisson S, Svalkvist A, Johnsson AA, Boijsen M, Flinck A, et al. Comparison of chest tomosynthesis and chest radiography for detection of pulmonary nodules: human observer study of clinical cases. Radiology 2008;249:1034-1041 https://doi.org/10.1148/radiol.2492080304
  31. Zheng B, Chakraborty DP, Rockette HE, Maitz GS, Gur D. A comparison of two data analyses from two observer performance studies using Jackknife ROC and JAFROC. Med Phys 2005;32:1031-1034 https://doi.org/10.1118/1.1884766
  32. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257:674-684 https://doi.org/10.1148/radiol.10100729
  33. Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, et al. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 2011;79:e1-e6
  34. Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 2009;30:586-595 https://doi.org/10.1002/jmri.21889
  35. Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, et al. Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol 2011;12:403-415 https://doi.org/10.3348/kjr.2011.12.4.403
  36. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006;16:1337-1345 https://doi.org/10.1007/s00330-005-0140-y
  37. Motosugi U, Ichikawa T, Nakajima H, Sou H, Sano M, Sano K, et al. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxideenhanced magnetic resonance imaging in the multidetectorrow computed tomography age? J Comput Assist Tomogr 2009;33:266-272 https://doi.org/10.1097/RCT.0b013e31817f5c82
  38. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, et al. Diagnosis of colorectal hepatic metastases: Contrastenhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxideenhanced magnetic resonance imaging with diffusionweighted imaging. J Magn Reson Imaging 2010;32:1132-1140 https://doi.org/10.1002/jmri.22360
  39. Onishi H, Murakami T, Kim T, Hori M, Iannaccone R, Kuwabara M, et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006;239:131-138 https://doi.org/10.1148/radiol.2383041825
  40. Schwartz L, Brody L, Brown K, Covey A, Tuorto S, Mazumdar M, et al. Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma. World J Surg 2006;30:1892-1899; discussion 1900-1901 https://doi.org/10.1007/s00268-005-0483-1
  41. Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdom Imaging 2012;37:74-82 https://doi.org/10.1007/s00261-011-9758-1

피인용 문헌

  1. Molecular Imaging: From Bench to Clinic vol.2014, pp.None, 2014, https://doi.org/10.1155/2014/357258
  2. High Spatial Resolution, Respiratory-Gated, T1-Weighted Magnetic Resonance Imaging of the Liver and the Biliary Tract During the Hepatobiliary Phase of Gadoxetic Acid–Enhanced Magnetic Resonance vol.38, pp.3, 2013, https://doi.org/10.1097/rct.0000000000000055
  3. Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI vol.6, pp.7, 2013, https://doi.org/10.4254/wjh.v6.i7.477
  4. Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity vol.40, pp.2, 2013, https://doi.org/10.1007/s00261-014-0214-x
  5. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging vol.40, pp.3, 2015, https://doi.org/10.1007/s00261-014-0244-4
  6. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation vol.274, pp.1, 2013, https://doi.org/10.1148/radiol.14140141
  7. Preoperative staging of gallbladder carcinoma using biliary MR imaging vol.41, pp.2, 2015, https://doi.org/10.1002/jmri.24537
  8. Added Value of Arterial Enhancement Fraction Color Maps for the Characterization of Small Hepatic Low-Attenuating Lesions in Patients with Colorectal Cancer vol.10, pp.2, 2015, https://doi.org/10.1371/journal.pone.0114819
  9. An overview of imaging techniques for liver metastases management vol.9, pp.12, 2013, https://doi.org/10.1586/17474124.2015.1092873
  10. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases vol.26, pp.12, 2013, https://doi.org/10.1007/s00330-016-4250-5
  11. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-ana vol.31, pp.11, 2013, https://doi.org/10.1007/s00384-016-2664-9
  12. Systemic treatment in breast cancer: a primer for radiologists vol.7, pp.1, 2013, https://doi.org/10.1007/s13244-015-0447-4
  13. Does the Reporting Quality of Diagnostic Test Accuracy Studies, as Defined by STARD 2015, Affect Citation? vol.17, pp.5, 2016, https://doi.org/10.3348/kjr.2016.17.5.706
  14. Selection and Reporting of Statistical Methods to Assess Reliability of a Diagnostic Test: Conformity to Recommended Methods in a Peer-Reviewed Journal vol.18, pp.6, 2017, https://doi.org/10.3348/kjr.2017.18.6.888
  15. Whole‐body PET/MRI for colorectal cancer staging: Is it the way forward? vol.45, pp.1, 2017, https://doi.org/10.1002/jmri.25337
  16. Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer vol.72, pp.6, 2013, https://doi.org/10.1016/j.crad.2017.01.011
  17. 18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine vol.12, pp.7, 2017, https://doi.org/10.1371/journal.pone.0180349
  18. Application of High-Speed T1 Sequences for High-Quality Hepatic Arterial Phase Magnetic Resonance Imaging: Intraindividual Comparison of Single and Multiple Arterial Phases vol.52, pp.10, 2013, https://doi.org/10.1097/rli.0000000000000378
  19. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges vol.288, pp.1, 2013, https://doi.org/10.1148/radiol.2018171187
  20. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy vol.210, pp.5, 2013, https://doi.org/10.2214/ajr.17.18310
  21. Evaluation of Transient Motion During Gadoxetic Acid–Enhanced Multiphasic Liver Magnetic Resonance Imaging Using Free-Breathing Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging vol.53, pp.1, 2013, https://doi.org/10.1097/rli.0000000000000409
  22. MRI-based Radiomics nomogram to detect primary rectal cancer with synchronous liver metastases vol.9, pp.None, 2013, https://doi.org/10.1038/s41598-019-39651-y
  23. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer vol.60, pp.4, 2019, https://doi.org/10.1177/0284185118788901
  24. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC vol.29, pp.6, 2013, https://doi.org/10.1007/s00330-018-5941-x
  25. Diagnostic performance of [18F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis vol.29, pp.7, 2013, https://doi.org/10.1007/s00330-018-5909-x
  26. Added Value of Contrast Medium in Whole-Body Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Comparison between Contrast-Enhanced and Non-Contrast-Enhanced Protocols vol.29, pp.1, 2013, https://doi.org/10.1159/000501497
  27. A clinical‐radiomic model for improved prognostication of surgical candidates with colorectal liver metastases vol.121, pp.2, 2020, https://doi.org/10.1002/jso.25783
  28. A Protease-Activated Fluorescent Probe Allows Rapid Visualization of Keratinocyte Carcinoma during Excision vol.80, pp.10, 2013, https://doi.org/10.1158/0008-5472.can-19-3067
  29. Differentiating Between an Atypical Hepatic Abscess and Tumor Metastasis Using Magnetic Resonance Imaging and Hepatobiliary Phase Imaging vol.14, pp.None, 2013, https://doi.org/10.2147/idr.s318291
  30. Shear-wave velocity for colorectal cancer liver metastases as a potential prognostic factor after chemotherapy: a preliminary study vol.76, pp.3, 2013, https://doi.org/10.1016/j.crad.2020.09.027
  31. Structured reporting of CT or MRI for perihilar cholangiocarcinoma: usefulness for clinical planning and interdisciplinary communication vol.39, pp.4, 2013, https://doi.org/10.1007/s11604-020-01068-3
  32. Imaging evaluation of the liver in oncology patients: A comparison of techniques vol.13, pp.12, 2013, https://doi.org/10.4254/wjh.v13.i12.1936